LIN ELIZABETH YEU exercised options at TARSUS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 3/17/2026ACC: 0001842190-26-000005
Director
Since Dec 2021
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.51K acquired · 2.51K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.51K
Price / share
—
Trade value
—
% of position
11.4%
3/15/2026
21.94K→24.45K
Total
Net shares
+2.51K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2026 | M · Option Exercise | +2.51K | — | — | 11.4% | 21.94K | 24.45K |
| Total | +2.51K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
2.51K shares
Shares
−2.51K
Strike price
Held after
7.53K
Exercisable
—
3/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2.51K shares | 3/15/2026 | M · Option Exercise | −2.51K | — | 7.53K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned6.36K
Common Stock
IndirectShares owned12.04K
Total
18.40K indirect18.40K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.36K | Indirect |
| Common Stock | 12.04K | Indirect |
| Total | 18.40K | 18.40K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported